Axsome Therapeutics’ AXSM Auvelity (AXS-05) was launched in the United States in 2022 for the treatment of major depressive disorder (MDD), making it the first approved drug in the company’s portfolio ...

For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...

In a breakthrough for people living with Parkinson’s, a new study has finally determined the structure of a protein linked to ...

The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to $430m in funding from ...

Researchers have made a breakthrough in the battle against Parkinson’s disease by solving a long-standing mystery, in a huge ...

Melbourne researchers have made a significant breakthrough in the fight against Parkinson's disease. Police have responded to a man allegedly wielding a knife inside a major Gold Coast shopping centre ...

WEHI researchers have made a huge leap forward in the fight against Parkinson's disease, solving a decades-long mystery that paves the way for development of new drugs to treat the condition.

Global Parkinson’s disease cases are projected to more than double to 25.2 million by 2050, driven largely by aging ...

Scientists have made a potentially “life-changing” discovery that could pave the way for new drugs to treat Parkinson’s ...

Researchers have discovered more about PINK1, a protein that’s directly tied to Parkinson’s disease. A team from Walter and Eliza Hall Institute in Australia has shown how the protein attaches to cell ...

New research provides key insights into the structure and function of PINK1, a protein linked to Parkinson's disease.

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.